Letter to the Editor: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease

Affiliations

¹ Department of Medicine, Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Lahore, Punjab, Pakistan.
² Tbilisi State Medical University, 33 Vazha-Pshavela Ave, 0186 Tbilisi, Georgia.

Comment

Sumayya Umar et al. Hepatology. 2023.

. 2023 Jul 1;78(1):E14-E15.

doi: 10.1097/HEP.0000000000000398. Epub 2023 Apr 11.

¹ Department of Medicine, Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Lahore, Punjab, Pakistan.
² Tbilisi State Medical University, 33 Vazha-Pshavela Ave, 0186 Tbilisi, Georgia.

No abstract available

Comment in

Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease.
Hartl L, Reiberger T, Trauner M. Hartl L, et al. Hepatology. 2023 Jul 1;78(1):E16-E17. doi: 10.1097/HEP.0000000000000399. Epub 2023 Apr 11. Hepatology. 2023. PMID: 37036261 No abstract available.

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, Simbrunner B, Bauer DJM, Eigenbauer E, Strassl R, Breuer M, Kimberger O, Laxar D, Lampichler K, Halilbasic E, Stättermayer AF, Ba-Ssalamah A, Mandorfer M, Scheiner B, Reiberger T, Trauner M. Hartl L, et al. Hepatology. 2022 Dec;76(6):1563-1575. doi: 10.1002/hep.32582. Epub 2022 Jun 18. Hepatology. 2022. PMID: 35596929 Free PMC article.

1. Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology. 2022;76:1563–75.
1. Nevola R, Criscuolo L, Beccia D, Delle Femine A, Ruocco R, Imbriani S, et al. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: roles of stage, etiology and vaccination. World J Gastroenterol. 2023;29:800–14.
1. Baldelli L, Marjot T, Barnes E, Barritt AS, Webb GJ, Moon AM. SARS-CoV-2 infection and liver disease: a review of pathogenesis and outcomes. Gut Liver. 2023;17:12–23.
1. Ekpanyapong S, Reddy KR. Liver and biliary tract disease in patients with coronavirus disease-2019 infection. Gastroenterol Clin North Am. 2023;52:13–36.